glp-1 constipation law office in west virginia What to know about packaged foods aimed at users of weight-loss drugs The hidden risks of GLP-1

It gives us pause to say for an average employer group out there if youre investing in this medication for your employees, dont expect to see a return in year one. According to Joseph Leach, M.D., Senior Vice President and Chief Medical Officer at Prime, We will need results of ongoing, multi-year studies to see if this treatment has downstream impacts on other health conditions, including cardiovascular events and diabetes development prevention, which are key benefits to weight loss management

the timing or feasibility of potential future partnerships or collaborations or expanded access to treatment options available on our platform

This led researchers to wonder if GIP agonists would even work in the population that needed them most

Higher doses being studied for obesity